Medical Care
Global Organoids Market Research Report 2025
- Apr 16, 25
- ID: 187091
- Pages: 75
- Figures: 71
- Views: 37
The global market for Organoids was valued at US$ 67 million in the year 2024 and is projected to reach a revised size of US$ 215 million by 2031, growing at a CAGR of 18.4% during the forecast period.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Organoids are a complex collection of cells grown in 3D culture medium that can summarize the various physiological and genomic characteristics of various tissues or organs. Organoids are micro-organs with three-dimensional structures that are cultivated in vitro using adult stem cells. They have highly similar genetic backgrounds and histological characteristics to organs in the body; they have complex structures similar to real organs and can partially simulate the physiological functions of the source tissues and organs; they simulate the endogenous environment to conduct research on tissue biology, development and regeneration, disease modeling, organ transplantation technology improvement, drug discovery/efficacy evaluation, and toxicology. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs").
A major driver of the organoids market is the increasing demand for advanced models in drug discovery and personalized medicine. Organoids, which mimic the structure and function of real human organs, provide a more accurate representation of human biology compared to traditional cell cultures or animal models. This enables pharmaceutical companies to conduct more precise preclinical testing, reducing the time and cost of drug development. Additionally, organoids are being increasingly used in personalized medicine, where they can help tailor treatments to individual patients by predicting how they will respond to specific therapies, particularly in cancer research.
One of the main challenges in the organoids market is the complexity and high cost of organoid development and maintenance. Creating organoids that accurately replicate human organs requires sophisticated techniques and specialized equipment, making the process expensive and technically demanding. Additionally, there are still limitations in scaling up production and standardizing protocols, which hinders widespread adoption in clinical settings. Regulatory hurdles and the need for more validation studies to ensure the reliability of organoids in predicting human responses also pose barriers to market growth.
This report aims to provide a comprehensive presentation of the global market for Organoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids.
The Organoids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
Segment by Type
Stem Cell Source
Tumor Cell Source
Segment by Application
Precision Medicine
Pharmaceutical R&D
Academics and Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoids company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Organoids are a complex collection of cells grown in 3D culture medium that can summarize the various physiological and genomic characteristics of various tissues or organs. Organoids are micro-organs with three-dimensional structures that are cultivated in vitro using adult stem cells. They have highly similar genetic backgrounds and histological characteristics to organs in the body; they have complex structures similar to real organs and can partially simulate the physiological functions of the source tissues and organs; they simulate the endogenous environment to conduct research on tissue biology, development and regeneration, disease modeling, organ transplantation technology improvement, drug discovery/efficacy evaluation, and toxicology. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs").
A major driver of the organoids market is the increasing demand for advanced models in drug discovery and personalized medicine. Organoids, which mimic the structure and function of real human organs, provide a more accurate representation of human biology compared to traditional cell cultures or animal models. This enables pharmaceutical companies to conduct more precise preclinical testing, reducing the time and cost of drug development. Additionally, organoids are being increasingly used in personalized medicine, where they can help tailor treatments to individual patients by predicting how they will respond to specific therapies, particularly in cancer research.
One of the main challenges in the organoids market is the complexity and high cost of organoid development and maintenance. Creating organoids that accurately replicate human organs requires sophisticated techniques and specialized equipment, making the process expensive and technically demanding. Additionally, there are still limitations in scaling up production and standardizing protocols, which hinders widespread adoption in clinical settings. Regulatory hurdles and the need for more validation studies to ensure the reliability of organoids in predicting human responses also pose barriers to market growth.
This report aims to provide a comprehensive presentation of the global market for Organoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids.
The Organoids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
Segment by Type
Stem Cell Source
Tumor Cell Source
Segment by Application
Precision Medicine
Pharmaceutical R&D
Academics and Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoids company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoids Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Source
1.2.3 Tumor Cell Source
1.3 Market by Application
1.3.1 Global Organoids Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Precision Medicine
1.3.3 Pharmaceutical R&D
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoids Market Perspective (2020-2031)
2.2 Global Organoids Growth Trends by Region
2.2.1 Global Organoids Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Organoids Historic Market Size by Region (2020-2025)
2.2.3 Organoids Forecasted Market Size by Region (2026-2031)
2.3 Organoids Market Dynamics
2.3.1 Organoids Industry Trends
2.3.2 Organoids Market Drivers
2.3.3 Organoids Market Challenges
2.3.4 Organoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoids Players by Revenue
3.1.1 Global Top Organoids Players by Revenue (2020-2025)
3.1.2 Global Organoids Revenue Market Share by Players (2020-2025)
3.2 Global Organoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Organoids Revenue
3.4 Global Organoids Market Concentration Ratio
3.4.1 Global Organoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoids Revenue in 2024
3.5 Global Key Players of Organoids Head office and Area Served
3.6 Global Key Players of Organoids, Product and Application
3.7 Global Key Players of Organoids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoids Breakdown Data by Type
4.1 Global Organoids Historic Market Size by Type (2020-2025)
4.2 Global Organoids Forecasted Market Size by Type (2026-2031)
5 Organoids Breakdown Data by Application
5.1 Global Organoids Historic Market Size by Application (2020-2025)
5.2 Global Organoids Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Organoids Market Size (2020-2031)
6.2 North America Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Organoids Market Size by Country (2020-2025)
6.4 North America Organoids Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoids Market Size (2020-2031)
7.2 Europe Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Organoids Market Size by Country (2020-2025)
7.4 Europe Organoids Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoids Market Size (2020-2031)
8.2 Asia-Pacific Organoids Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Organoids Market Size by Region (2020-2025)
8.4 Asia-Pacific Organoids Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoids Market Size (2020-2031)
9.2 Latin America Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Organoids Market Size by Country (2020-2025)
9.4 Latin America Organoids Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoids Market Size (2020-2031)
10.2 Middle East & Africa Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Organoids Market Size by Country (2020-2025)
10.4 Middle East & Africa Organoids Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Organoids Introduction
11.1.4 Thermo Fisher Scientific Revenue in Organoids Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Organoids Introduction
11.2.4 Merck Revenue in Organoids Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Corning
11.3.1 Corning Company Details
11.3.2 Corning Business Overview
11.3.3 Corning Organoids Introduction
11.3.4 Corning Revenue in Organoids Business (2020-2025)
11.3.5 Corning Recent Development
11.4 STEMCELL Technologies
11.4.1 STEMCELL Technologies Company Details
11.4.2 STEMCELL Technologies Business Overview
11.4.3 STEMCELL Technologies Organoids Introduction
11.4.4 STEMCELL Technologies Revenue in Organoids Business (2020-2025)
11.4.5 STEMCELL Technologies Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Organoids Introduction
11.5.4 Lonza Revenue in Organoids Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Prellis Biologics
11.6.1 Prellis Biologics Company Details
11.6.2 Prellis Biologics Business Overview
11.6.3 Prellis Biologics Organoids Introduction
11.6.4 Prellis Biologics Revenue in Organoids Business (2020-2025)
11.6.5 Prellis Biologics Recent Development
11.7 amsbio
11.7.1 amsbio Company Details
11.7.2 amsbio Business Overview
11.7.3 amsbio Organoids Introduction
11.7.4 amsbio Revenue in Organoids Business (2020-2025)
11.7.5 amsbio Recent Development
11.8 Tanwang Medical
11.8.1 Tanwang Medical Company Details
11.8.2 Tanwang Medical Business Overview
11.8.3 Tanwang Medical Organoids Introduction
11.8.4 Tanwang Medical Revenue in Organoids Business (2020-2025)
11.8.5 Tanwang Medical Recent Development
11.9 Ketu Medicine
11.9.1 Ketu Medicine Company Details
11.9.2 Ketu Medicine Business Overview
11.9.3 Ketu Medicine Organoids Introduction
11.9.4 Ketu Medicine Revenue in Organoids Business (2020-2025)
11.9.5 Ketu Medicine Recent Development
11.10 Chuangxin International
11.10.1 Chuangxin International Company Details
11.10.2 Chuangxin International Business Overview
11.10.3 Chuangxin International Organoids Introduction
11.10.4 Chuangxin International Revenue in Organoids Business (2020-2025)
11.10.5 Chuangxin International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoids Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Source
1.2.3 Tumor Cell Source
1.3 Market by Application
1.3.1 Global Organoids Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Precision Medicine
1.3.3 Pharmaceutical R&D
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoids Market Perspective (2020-2031)
2.2 Global Organoids Growth Trends by Region
2.2.1 Global Organoids Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Organoids Historic Market Size by Region (2020-2025)
2.2.3 Organoids Forecasted Market Size by Region (2026-2031)
2.3 Organoids Market Dynamics
2.3.1 Organoids Industry Trends
2.3.2 Organoids Market Drivers
2.3.3 Organoids Market Challenges
2.3.4 Organoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoids Players by Revenue
3.1.1 Global Top Organoids Players by Revenue (2020-2025)
3.1.2 Global Organoids Revenue Market Share by Players (2020-2025)
3.2 Global Organoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Organoids Revenue
3.4 Global Organoids Market Concentration Ratio
3.4.1 Global Organoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoids Revenue in 2024
3.5 Global Key Players of Organoids Head office and Area Served
3.6 Global Key Players of Organoids, Product and Application
3.7 Global Key Players of Organoids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoids Breakdown Data by Type
4.1 Global Organoids Historic Market Size by Type (2020-2025)
4.2 Global Organoids Forecasted Market Size by Type (2026-2031)
5 Organoids Breakdown Data by Application
5.1 Global Organoids Historic Market Size by Application (2020-2025)
5.2 Global Organoids Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Organoids Market Size (2020-2031)
6.2 North America Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Organoids Market Size by Country (2020-2025)
6.4 North America Organoids Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoids Market Size (2020-2031)
7.2 Europe Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Organoids Market Size by Country (2020-2025)
7.4 Europe Organoids Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoids Market Size (2020-2031)
8.2 Asia-Pacific Organoids Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Organoids Market Size by Region (2020-2025)
8.4 Asia-Pacific Organoids Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoids Market Size (2020-2031)
9.2 Latin America Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Organoids Market Size by Country (2020-2025)
9.4 Latin America Organoids Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoids Market Size (2020-2031)
10.2 Middle East & Africa Organoids Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Organoids Market Size by Country (2020-2025)
10.4 Middle East & Africa Organoids Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Organoids Introduction
11.1.4 Thermo Fisher Scientific Revenue in Organoids Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Organoids Introduction
11.2.4 Merck Revenue in Organoids Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Corning
11.3.1 Corning Company Details
11.3.2 Corning Business Overview
11.3.3 Corning Organoids Introduction
11.3.4 Corning Revenue in Organoids Business (2020-2025)
11.3.5 Corning Recent Development
11.4 STEMCELL Technologies
11.4.1 STEMCELL Technologies Company Details
11.4.2 STEMCELL Technologies Business Overview
11.4.3 STEMCELL Technologies Organoids Introduction
11.4.4 STEMCELL Technologies Revenue in Organoids Business (2020-2025)
11.4.5 STEMCELL Technologies Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Organoids Introduction
11.5.4 Lonza Revenue in Organoids Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Prellis Biologics
11.6.1 Prellis Biologics Company Details
11.6.2 Prellis Biologics Business Overview
11.6.3 Prellis Biologics Organoids Introduction
11.6.4 Prellis Biologics Revenue in Organoids Business (2020-2025)
11.6.5 Prellis Biologics Recent Development
11.7 amsbio
11.7.1 amsbio Company Details
11.7.2 amsbio Business Overview
11.7.3 amsbio Organoids Introduction
11.7.4 amsbio Revenue in Organoids Business (2020-2025)
11.7.5 amsbio Recent Development
11.8 Tanwang Medical
11.8.1 Tanwang Medical Company Details
11.8.2 Tanwang Medical Business Overview
11.8.3 Tanwang Medical Organoids Introduction
11.8.4 Tanwang Medical Revenue in Organoids Business (2020-2025)
11.8.5 Tanwang Medical Recent Development
11.9 Ketu Medicine
11.9.1 Ketu Medicine Company Details
11.9.2 Ketu Medicine Business Overview
11.9.3 Ketu Medicine Organoids Introduction
11.9.4 Ketu Medicine Revenue in Organoids Business (2020-2025)
11.9.5 Ketu Medicine Recent Development
11.10 Chuangxin International
11.10.1 Chuangxin International Company Details
11.10.2 Chuangxin International Business Overview
11.10.3 Chuangxin International Organoids Introduction
11.10.4 Chuangxin International Revenue in Organoids Business (2020-2025)
11.10.5 Chuangxin International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Organoids Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stem Cell Source
Table 3. Key Players of Tumor Cell Source
Table 4. Global Organoids Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Organoids Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Organoids Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Organoids Market Share by Region (2020-2025)
Table 8. Global Organoids Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Organoids Market Share by Region (2026-2031)
Table 10. Organoids Market Trends
Table 11. Organoids Market Drivers
Table 12. Organoids Market Challenges
Table 13. Organoids Market Restraints
Table 14. Global Organoids Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Organoids Market Share by Players (2020-2025)
Table 16. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Table 17. Ranking of Global Top Organoids Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Organoids Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Organoids, Headquarters and Area Served
Table 20. Global Key Players of Organoids, Product and Application
Table 21. Global Key Players of Organoids, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Organoids Revenue Market Share by Type (2020-2025)
Table 25. Global Organoids Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Organoids Revenue Market Share by Type (2026-2031)
Table 27. Global Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Organoids Revenue Market Share by Application (2020-2025)
Table 29. Global Organoids Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Organoids Revenue Market Share by Application (2026-2031)
Table 31. North America Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Organoids Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Organoids Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Organoids Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Details
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Organoids Product
Table 49. Thermo Fisher Scientific Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Organoids Product
Table 54. Merck Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Corning Company Details
Table 57. Corning Business Overview
Table 58. Corning Organoids Product
Table 59. Corning Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 60. Corning Recent Development
Table 61. STEMCELL Technologies Company Details
Table 62. STEMCELL Technologies Business Overview
Table 63. STEMCELL Technologies Organoids Product
Table 64. STEMCELL Technologies Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 65. STEMCELL Technologies Recent Development
Table 66. Lonza Company Details
Table 67. Lonza Business Overview
Table 68. Lonza Organoids Product
Table 69. Lonza Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 70. Lonza Recent Development
Table 71. Prellis Biologics Company Details
Table 72. Prellis Biologics Business Overview
Table 73. Prellis Biologics Organoids Product
Table 74. Prellis Biologics Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 75. Prellis Biologics Recent Development
Table 76. amsbio Company Details
Table 77. amsbio Business Overview
Table 78. amsbio Organoids Product
Table 79. amsbio Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 80. amsbio Recent Development
Table 81. Tanwang Medical Company Details
Table 82. Tanwang Medical Business Overview
Table 83. Tanwang Medical Organoids Product
Table 84. Tanwang Medical Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 85. Tanwang Medical Recent Development
Table 86. Ketu Medicine Company Details
Table 87. Ketu Medicine Business Overview
Table 88. Ketu Medicine Organoids Product
Table 89. Ketu Medicine Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 90. Ketu Medicine Recent Development
Table 91. Chuangxin International Company Details
Table 92. Chuangxin International Business Overview
Table 93. Chuangxin International Organoids Product
Table 94. Chuangxin International Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 95. Chuangxin International Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Organoids Picture
Figure 2. Global Organoids Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Organoids Market Share by Type: 2024 VS 2031
Figure 4. Stem Cell Source Features
Figure 5. Tumor Cell Source Features
Figure 6. Global Organoids Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Organoids Market Share by Application: 2024 VS 2031
Figure 8. Precision Medicine Case Studies
Figure 9. Pharmaceutical R&D Case Studies
Figure 10. Academics and Research Institutes Case Studies
Figure 11. Organoids Report Years Considered
Figure 12. Global Organoids Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Organoids Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Organoids Market Share by Region: 2024 VS 2031
Figure 15. Global Organoids Market Share by Players in 2024
Figure 16. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Organoids Revenue in 2024
Figure 18. North America Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Organoids Market Share by Country (2020-2031)
Figure 20. United States Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Organoids Market Share by Country (2020-2031)
Figure 24. Germany Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Organoids Market Share by Region (2020-2031)
Figure 32. China Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Organoids Market Share by Country (2020-2031)
Figure 40. Mexico Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Organoids Market Share by Country (2020-2031)
Figure 44. Turkey Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Organoids Business (2020-2025)
Figure 49. Corning Revenue Growth Rate in Organoids Business (2020-2025)
Figure 50. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Organoids Business (2020-2025)
Figure 52. Prellis Biologics Revenue Growth Rate in Organoids Business (2020-2025)
Figure 53. amsbio Revenue Growth Rate in Organoids Business (2020-2025)
Figure 54. Tanwang Medical Revenue Growth Rate in Organoids Business (2020-2025)
Figure 55. Ketu Medicine Revenue Growth Rate in Organoids Business (2020-2025)
Figure 56. Chuangxin International Revenue Growth Rate in Organoids Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Organoids Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stem Cell Source
Table 3. Key Players of Tumor Cell Source
Table 4. Global Organoids Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Organoids Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Organoids Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Organoids Market Share by Region (2020-2025)
Table 8. Global Organoids Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Organoids Market Share by Region (2026-2031)
Table 10. Organoids Market Trends
Table 11. Organoids Market Drivers
Table 12. Organoids Market Challenges
Table 13. Organoids Market Restraints
Table 14. Global Organoids Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Organoids Market Share by Players (2020-2025)
Table 16. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Table 17. Ranking of Global Top Organoids Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Organoids Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Organoids, Headquarters and Area Served
Table 20. Global Key Players of Organoids, Product and Application
Table 21. Global Key Players of Organoids, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Organoids Revenue Market Share by Type (2020-2025)
Table 25. Global Organoids Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Organoids Revenue Market Share by Type (2026-2031)
Table 27. Global Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Organoids Revenue Market Share by Application (2020-2025)
Table 29. Global Organoids Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Organoids Revenue Market Share by Application (2026-2031)
Table 31. North America Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Organoids Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Organoids Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Organoids Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Organoids Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Organoids Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Organoids Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Details
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Organoids Product
Table 49. Thermo Fisher Scientific Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Organoids Product
Table 54. Merck Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Corning Company Details
Table 57. Corning Business Overview
Table 58. Corning Organoids Product
Table 59. Corning Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 60. Corning Recent Development
Table 61. STEMCELL Technologies Company Details
Table 62. STEMCELL Technologies Business Overview
Table 63. STEMCELL Technologies Organoids Product
Table 64. STEMCELL Technologies Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 65. STEMCELL Technologies Recent Development
Table 66. Lonza Company Details
Table 67. Lonza Business Overview
Table 68. Lonza Organoids Product
Table 69. Lonza Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 70. Lonza Recent Development
Table 71. Prellis Biologics Company Details
Table 72. Prellis Biologics Business Overview
Table 73. Prellis Biologics Organoids Product
Table 74. Prellis Biologics Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 75. Prellis Biologics Recent Development
Table 76. amsbio Company Details
Table 77. amsbio Business Overview
Table 78. amsbio Organoids Product
Table 79. amsbio Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 80. amsbio Recent Development
Table 81. Tanwang Medical Company Details
Table 82. Tanwang Medical Business Overview
Table 83. Tanwang Medical Organoids Product
Table 84. Tanwang Medical Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 85. Tanwang Medical Recent Development
Table 86. Ketu Medicine Company Details
Table 87. Ketu Medicine Business Overview
Table 88. Ketu Medicine Organoids Product
Table 89. Ketu Medicine Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 90. Ketu Medicine Recent Development
Table 91. Chuangxin International Company Details
Table 92. Chuangxin International Business Overview
Table 93. Chuangxin International Organoids Product
Table 94. Chuangxin International Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 95. Chuangxin International Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Organoids Picture
Figure 2. Global Organoids Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Organoids Market Share by Type: 2024 VS 2031
Figure 4. Stem Cell Source Features
Figure 5. Tumor Cell Source Features
Figure 6. Global Organoids Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Organoids Market Share by Application: 2024 VS 2031
Figure 8. Precision Medicine Case Studies
Figure 9. Pharmaceutical R&D Case Studies
Figure 10. Academics and Research Institutes Case Studies
Figure 11. Organoids Report Years Considered
Figure 12. Global Organoids Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Organoids Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Organoids Market Share by Region: 2024 VS 2031
Figure 15. Global Organoids Market Share by Players in 2024
Figure 16. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Organoids Revenue in 2024
Figure 18. North America Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Organoids Market Share by Country (2020-2031)
Figure 20. United States Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Organoids Market Share by Country (2020-2031)
Figure 24. Germany Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Organoids Market Share by Region (2020-2031)
Figure 32. China Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Organoids Market Share by Country (2020-2031)
Figure 40. Mexico Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Organoids Market Share by Country (2020-2031)
Figure 44. Turkey Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Organoids Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Organoids Business (2020-2025)
Figure 49. Corning Revenue Growth Rate in Organoids Business (2020-2025)
Figure 50. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Organoids Business (2020-2025)
Figure 52. Prellis Biologics Revenue Growth Rate in Organoids Business (2020-2025)
Figure 53. amsbio Revenue Growth Rate in Organoids Business (2020-2025)
Figure 54. Tanwang Medical Revenue Growth Rate in Organoids Business (2020-2025)
Figure 55. Ketu Medicine Revenue Growth Rate in Organoids Business (2020-2025)
Figure 56. Chuangxin International Revenue Growth Rate in Organoids Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232